Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019

Renewed interest in developing vaccines against Neisseria gonorrhoeae has been sparked by the increasing threat of gonococcal antimicrobial resistance (AMR) and growing optimism that gonococcal vaccines are biologically feasible. Evidence suggests serogroup B Neisseria meningitidis vaccines might pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Gottlieb, Sami L., Ndowa, Francis, Hook, Edward W., Deal, Carolyn, Bachmann, Laura, Abu-Raddad, Laith, Chen, Xiang-Sheng, Jerse, Ann, Low, Nicola, MacLennan, Calman A., Petousis-Harris, Helen, Seib, Kate L., Unemo, Magnus, Vincent, Leah, Giersing, Birgitte K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273195/
https://www.ncbi.nlm.nih.gov/pubmed/32359875
http://dx.doi.org/10.1016/j.vaccine.2020.02.073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273195/
https://www.ncbi.nlm.nih.gov/pubmed/32359875
http://dx.doi.org/10.1016/j.vaccine.2020.02.073

Ejemplares similares